U.S. COMPANY FILING
CVS HEALTH Corp — Form 10-K filed 2026-02-10
Filing text preview
CVS Health's 2025 revenue rose 7.8% to $402.1 billion, but net income fell 61.7% to $1.77 billion due to a $5.7 billion goodwill impairment, $1.2 billion legacy litigation charges, and $320 million opioid litigation charge. The Health Services segment reported a GAAP loss, though adjusted operating income grew. The company faces regulatory, competitive, and drug pricing pressures, with negative credit outlooks.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record